A new batch of a pharmaceutical abortion pill with a shelf life and enough supply to last until 2028 was added to Oregon’s three-year stockpile.
At the request of Governor Tina Kotek, Oregon Health & Science University acquired 22,500 doses of mifepristone last year. After a federal judge in Texas decided to halt the Food and Drug Administration’s clearance of mifepristone, Oregon joined a number of other states that started hoarding the medication. But in June, the U.S. Supreme Court intervened and rejected the case.
Misoprostol with mifepristone can be used to treat miscarriages and terminate pregnancies. The initial state stockpile was scheduled to run out in September 2025.
Kotek claimed that in reaction to the nationwide election results on November 5, the state increased its supply of the abortion pill. After the general election, Republicans took over both the White House and Congress, and some abortion providers are concerned that access may be jeopardized even in areas like Oregon where abortion is legal.
Kotek stated in a statement this week that federal attacks on our reproductive rights are not unique to Oregon. In our state, providers will continue to provide these vital services without fear or intimidation, and patients will continue to obtain the drugs they require.
In Oregon, medicine is used in over 65% of abortions. The FDA approved the mifepristone and misoprostol procedure in 2000, and it is used in the great majority of such cases.
–Kristine de Leon uncovers stories about data enterprise, small company, retail, and consumer health.
[email protected] is her email address.
Your support is essential to our journalism.Sign up now.
Note: Every piece of content is rigorously reviewed by our team of experienced writers and editors to ensure its accuracy. Our writers use credible sources and adhere to strict fact-checking protocols to verify all claims and data before publication. If an error is identified, we promptly correct it and strive for transparency in all updates, feel free to reach out to us via email. We appreciate your trust and support!
